Your browser doesn't support javascript.
loading
The Premenopausal Breast Cancer Collaboration: A Pooling Project of Studies Participating in the National Cancer Institute Cohort Consortium.
Nichols, Hazel B; Schoemaker, Minouk J; Wright, Lauren B; McGowan, Craig; Brook, Mark N; McClain, Kathleen M; Jones, Michael E; Adami, Hans-Olov; Agnoli, Claudia; Baglietto, Laura; Bernstein, Leslie; Bertrand, Kimberly A; Blot, William J; Boutron-Ruault, Marie-Christine; Butler, Lesley; Chen, Yu; Doody, Michele M; Dossus, Laure; Eliassen, A Heather; Giles, Graham G; Gram, Inger T; Hankinson, Susan E; Hoffman-Bolton, Judy; Kaaks, Rudolf; Key, Timothy J; Kirsh, Victoria A; Kitahara, Cari M; Koh, Woon-Puay; Larsson, Susanna C; Lund, Eiliv; Ma, Huiyan; Merritt, Melissa A; Milne, Roger L; Navarro, Carmen; Overvad, Kim; Ozasa, Kotaro; Palmer, Julie R; Peeters, Petra H; Riboli, Elio; Rohan, Thomas E; Sadakane, Atsuko; Sund, Malin; Tamimi, Rulla M; Trichopoulou, Antonia; Vatten, Lars; Visvanathan, Kala; Weiderpass, Elisabete; Willett, Walter C; Wolk, Alicja; Zeleniuch-Jacquotte, Anne.
Afiliação
  • Nichols HB; University of North Carolina, Gillings School of Global Public Health, Chapel Hill, North Carolina. hazel.nichols@unc.edu.
  • Schoemaker MJ; Division of Genetics and Epidemiology, The Institute of Cancer Research, Sutton, United Kingdom.
  • Wright LB; Division of Genetics and Epidemiology, The Institute of Cancer Research, Sutton, United Kingdom.
  • McGowan C; University of North Carolina, Gillings School of Global Public Health, Chapel Hill, North Carolina.
  • Brook MN; Division of Genetics and Epidemiology, The Institute of Cancer Research, Sutton, United Kingdom.
  • McClain KM; University of North Carolina, Gillings School of Global Public Health, Chapel Hill, North Carolina.
  • Jones ME; Division of Genetics and Epidemiology, The Institute of Cancer Research, Sutton, United Kingdom.
  • Adami HO; Karolinska Institutet, MEB, University of Oslo Institute of Health and Society, Sweden, Norway.
  • Agnoli C; Fondazione IRCCS Istituto Nazionale dei Tumori, Italy, France.
  • Baglietto L; Centre for Research in Epidemiology and Population Health (CESP), France.
  • Bernstein L; Beckman Research Institute of City of Hope, Monrovia, California.
  • Bertrand KA; Slone Epidemiology Center at Boston University, Boston, Massachusetts.
  • Blot WJ; Division of Epidemiology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee.
  • Boutron-Ruault MC; Centre for Research in Epidemiology and Population Health (CESP), France.
  • Butler L; University of Pittsburgh Graduate School of Public Health, University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania.
  • Chen Y; NYU School of Medicine, New York, New York.
  • Doody MM; Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, Maryland.
  • Dossus L; International Agency for Research on Cancer, France.
  • Eliassen AH; Channing Division of Network Medicine, Brigham and Women's Hospital, Harvard T.H. Chan School of Public Health and Harvard Medical School, Boston, Massachusetts.
  • Giles GG; Cancer Council Victoria, University of Melbourne, Melbourne, Australia.
  • Gram IT; University of Tromsø, The Arctic University of Norway, Tromsø, Norway.
  • Hankinson SE; Department of Biostatistics and Epidemiology, School of Public Health and Health Sciences, University of Massachusetts, Boston, Massachusetts.
  • Hoffman-Bolton J; Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
  • Kaaks R; Division of Cancer Epidemiology, DKFZ, Heidelberg, Germany.
  • Key TJ; University of Oxford, Oxford, United Kingdom.
  • Kirsh VA; Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.
  • Kitahara CM; Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, Maryland.
  • Koh WP; Duke-NUS Medical School, Singapore.
  • Larsson SC; Karolinska Institutet, Institute of Environmental Medicine, Stockholm, Sweden.
  • Lund E; UiT (University of Tromsø), Tromsø, Norway.
  • Ma H; Beckman Research Institute of City of Hope, Monrovia, California.
  • Merritt MA; School of Public Health, Imperial College London, United Kingdom.
  • Milne RL; Cancer Council Victoria, University of Melbourne, Melbourne, Australia.
  • Navarro C; Department of Epidemiology, Murcia Regional Health Council, IMIB-Arrixaca, Murcia, Spain.
  • Overvad K; CIBER Epidemiología y Salud Pública (CIBERESP); Department of Health and Social Sciences, Universidad de Murcia, Murcia, Spain.
  • Ozasa K; Department of Public Health, Section for Epidemiology, Aarhus University, Aarhus, Denmark.
  • Palmer JR; Radiation Effects Research Foundation, Hiroshima, Japan.
  • Peeters PH; Slone Epidemiology Center at Boston University, Boston, Massachusetts.
  • Riboli E; University Medical Center, Utrecht, the Netherlands.
  • Rohan TE; School of Public Health, Imperial College London, United Kingdom.
  • Sadakane A; Albert Einstein College of Medicine, Bronx, New York.
  • Sund M; Radiation Effects Research Foundation, Hiroshima, Japan.
  • Tamimi RM; Umeå University, Umeå, Sweden.
  • Trichopoulou A; Channing Division of Network Medicine, Brigham and Women's Hospital, Harvard T.H. Chan School of Public Health and Harvard Medical School, Boston, Massachusetts.
  • Vatten L; Hellenic Health Foundation, Greece.
  • Visvanathan K; Norwegian University of Science and Technology, Trondheim, Norway.
  • Weiderpass E; Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
  • Willett WC; Johns Hopkins School of Medicine, Baltimore, Maryland.
  • Wolk A; Karolinska Institutet, Department of Epidemiology and Biostatistics, Oslo, Norway.
  • Zeleniuch-Jacquotte A; Department of Research, Head, Group of Etiological Cancer Research, Cancer Registry of Norway, Institute of Population-Based Cancer Research, Oslo, Norway.
Cancer Epidemiol Biomarkers Prev ; 26(9): 1360-1369, 2017 09.
Article em En | MEDLINE | ID: mdl-28600297
ABSTRACT
Breast cancer is a leading cancer diagnosis among premenopausal women around the world. Unlike rates in postmenopausal women, incidence rates of advanced breast cancer have increased in recent decades for premenopausal women. Progress in identifying contributors to breast cancer risk among premenopausal women has been constrained by the limited numbers of premenopausal breast cancer cases in individual studies and resulting low statistical power to subcategorize exposures or to study specific subtypes. The Premenopausal Breast Cancer Collaborative Group was established to facilitate cohort-based analyses of risk factors for premenopausal breast cancer by pooling individual-level data from studies participating in the United States National Cancer Institute Cohort Consortium. This article describes the Group, including the rationale for its initial aims related to pregnancy, obesity, and physical activity. We also describe the 20 cohort studies with data submitted to the Group by June 2016. The infrastructure developed for this work can be leveraged to support additional investigations. Cancer Epidemiol Biomarkers Prev; 26(9); 1360-9. ©2017 AACR.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama Idioma: En Ano de publicação: 2017 Tipo de documento: Article